$2.015
+0.279 (+13.84%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ABOS por análisis de gráficos similares
Alphio's ABOS stock price prediction model matches the current Acumen Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.03 (+0.95%). The 1-week path is $1.89 (-6.17%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Acumen Pharmaceuticals Inc?
Acumen Pharmaceuticals Inc is not a good buy right now due to its current price of $1.69, a very low RSI of 18.698 indicating oversold conditions, and a significant 5-day price drop of 21.03%. The company continues to report substantial net losses, with Q2 2026 showing a loss of $32.72 million, which raises concerns about its financial stability. Although there is potential upside as indicated by the analyst price target of $5, the immediate risks outweigh this potential reward.
ABOS cerró en $2.02 el Tuesday, tras subir +13.84%
Acumen Pharmaceuticals Inc (ABOS) last closed at $2.015, gaining +13.84%. These facts feed the 1-day and 1-week ABOS price prediction above.
Factores de la previsión
Los factores de la previsión de Acumen Pharmaceuticals Inc (ABOS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ABOS, ordenadas por similitud.
Análisis de estacionalidad de ABOS
Historically the probability of a positive October return for ABOS is 43.33%. March offers the highest probability of a positive month at 52.38%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ABOS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $1.66 | $1.71 | $2.00 | -15.15% |
| Nov 2026 | $1.17 | $1.41 | $1.48 | -30.25% |
| Dec 2026 | $1.39 | $1.52 | $1.62 | -24.68% |
En 2026, se proyecta que Acumen Pharmaceuticals Inc (ABOS) oscile entre $1.17 y $2.00.
Previsión mensual de Acumen Pharmaceuticals Inc para 2026
En Oct de 2026, se proyecta que Acumen Pharmaceuticals Inc promedie $1.71, con un mínimo de $1.66 y un máximo de $2.00.
En Nov de 2026, se proyecta que Acumen Pharmaceuticals Inc promedie $1.41, con un mínimo de $1.17 y un máximo de $1.48.
En Dec de 2026, se proyecta que Acumen Pharmaceuticals Inc promedie $1.52, con un mínimo de $1.39 y un máximo de $1.62.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.